MiNA Therapeutics
Robert has over 40 years of experience in academic medicine, being a recognised leader in biomedical research, management and governance. He has held various leadership roles in a range of hospitals and laboratories. Prior roles also include his Presidency of the Academy of Medical Sciences, Membership of the UK Council for Science and Technology, and Chairmanship of the UK MHRA Clinical Trials Expert Advisory Group. Robert currently sits on the Board of directors at Quell Therapeutics. In 2012, Robert was Knighted in the Queen’s Birthday Honours for his services to academic medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
MiNA Therapeutics
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.